Veronica Mann lost her only child Rashad Banks to lung cancer at 29 years old nearly four ... It’s something that they will remember.” A CT senator opposes Trump executive order on drug ...

Although immunotherapies and biomarker-driven interventions have transformed lung cancer outcomes, Martin Edelman, MD, Fox Chase Cancer Center, highlighted the present challenge hindering ...

Rory Londer's third "walk of gratitude" around the Mayo Clinic campus coincides with an expansion of support services for lung cancer patients in Rochester Rory Londer celebrates the fifth ...

joins John Williams to talk about performing the first double-lung and liver transplant for advanced lung cancer in the U.S. Dr. Nadig tells John about the procedure, how transplants are dependent on ...

Although targeted therapies and immunotherapy have improved survival outcomes in many patients with lung cancer, these therapies come at a cost, not only financially but also in terms of ...

Akeso and Summit Therapeutics’ giant-killing, PD-1xVEGF bispecific antibody ivonescimab has posted another phase 3 trial win in lung cancer, this time as part of a chemotherapy combination.

Lung and bronchus cancer saw the biggest decline in deaths, falling by 4.5% each year in that four-year timeframe, according to the report. “This is largely due to early and more effective ...

Artificial Intelligence can detect signs of lung cancer up to four months more quickly than family doctors, a study by researchers at Amsterdam’s UMC teaching hospital has shown. The researchers ...

For a decade, Linda Jacobs has fought breast cancer, gritting through radiation and immunotherapy treatments to keep her disease under control. But two years ago, she took a turn for the worse ...

Bayer has advanced its small-molecule drug BAY 2927088 into phase 3 for non-small cell lung cancer (NSCLC) with HER2 activating mutations, one of the drugs central to the company’s plan to ...

At the World Conference on Lung Cancer (WCLC) in San Diego, interim results from the dose optimisation part of the Ideate-Lung01 trial showed the benefit of the 12 mg/kg dose of the antibody-drug ...